Literature DB >> 6275048

Immunological, biochemical, ultrastructural, and electrophysiological characteristics of a human glioblastoma-derived cell culture line.

P M Black, P L Kornblith, P F Davison, T M Liszczak, L P Merk, B H Smith, P E McKeever, E A Quindlen.   

Abstract

This report presents the results of a study using multiple techniques of the established human cell line, LM, which has been developed in culture medium from a patient with a right temporoparietal glioblastoma. This cell line has human subtetraploid karyotype and has several features of a transformed line in culture. These include continuous propagation for 10 years, ability to form tumor nodules when transplanted into immunologically suppressed hamsters, and pleomorphic appearance. Ultrastructurally, it is characterized by multiple nuclei, few actin cables, and numerous surface-membrane microvilli, as well as abundant 9- to 10-nm cytoplasmic filaments. By its immunological reactivity, the line can be shown to contain glial fibrillary acidic protein at low levels, consistent with its glial origin and continued nature. Dibutyryl cyclic adenosine monophosphate (db-cAMP) induces formation of long astrocytic-like processes as well. Its membrane electrical characteristics include a low resting membrane potential and short time constant. Used in a microtiter antiglioma antibody cytotoxicity assay, LM yields a positive reaction to antibodies in the sera of 80% of patients with astrocytomas and only 9% of normal blood-bank donors, suggesting that it shares common antigens with other astrocytic tumor lines. The varied characteristics of this glioblastoma-derived line emphasize the "multiforme" nature on the neoplasm and suggest that for characterization of any such line, multiple parameters are necessary to allow comparison with other long-term glioblastoma lines in the literature. The usefulness of the LM line in in vitro cell biological, immunological, chemotherapeutic, and radiobiological studies of gliomas makes such efforts very worthwhile.

Entities:  

Mesh:

Year:  1982        PMID: 6275048     DOI: 10.3171/jns.1982.56.1.0062

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  15 in total

1.  Establishment and characterization of five cell lines derived from human malignant gliomas.

Authors:  J T Rutka; J R Giblin; D Y Dougherty; H C Liu; J R McCulloch; C W Bell; R S Stern; C B Wilson; M L Rosenblum
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  DNA in human glioblastomas. A flow-fluorescence cytometrical examination of 96 tumors.

Authors:  F W Spaar; U Spaar
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

3.  Flowcytometric and cytogenetic analysis of human cultured cell lines derived from high- and low-grade astrocytomas.

Authors:  N Shitara; P E McKeever; J Whang-Peng; T Knutsen; B H Smith; P L Kornblith
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

4.  Imaging of a glioma using peripheral benzodiazepine receptor ligands.

Authors:  S Starosta-Rubinstein; B J Ciliax; J B Penney; P McKeever; A B Young
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Selective cytoplasmic and membrane changes induced by cisplatinum.

Authors:  M A Oberc-Greenwood; B H Smith; C Cooke; C Pepin; P L Kornblith
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

6.  Products of cells from gliomas: IX. Evidence that two fundamentally different mechanisms change extracellular matrix expression by gliomas.

Authors:  P E McKeever; J Varani; S M Papadopoulos; M Wang; J P McCoy
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Cyclic nucleotides in experimental and human brain tumors.

Authors:  G Racagni; S Pezzotta; M T Giordana; E Iuliano; I Mocchetti; G Spanu; G Sangiovanni; P Paoletti
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

8.  Membrane and cytoplasmic changes in 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU)-sensitive and resistant human malignant glioma-derived cell lines.

Authors:  B H Smith; M Vaughan; M A Greenwood; P L Kornblith; A Robinson; N Shitara; P E McKeever
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

9.  Morphologic, immunologic, biochemical, and cytogenetic characteristics of the human glioblastoma-derived cell line, SNB-19.

Authors:  W C Welch; R S Morrison; J L Gross; S M Gollin; R B Kitson; R H Goldfarb; K A Giuliano; M K Bradley; P L Kornblith
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-09       Impact factor: 2.416

10.  Glucose metabolism in human gliomas: correspondence of in situ and in vitro metabolic rates and altered energy metabolism.

Authors:  J Galarraga; D J Loreck; J F Graham; R L DeLaPaz; B H Smith; D Hallgren; C J Cummins
Journal:  Metab Brain Dis       Date:  1986-12       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.